Shattuck Labs beruft Shoba Ravichandran zur Senior Vice President Clinical Development

• Shattuck Labs beruft Shoba Ravichandran zur Senior Vice President Clinical Development.
• Ravichandran war zuvor bei Novartis Senior Global Program Clinical Head; sie führte Cosentyx zur HS-Zulassung.
• Bei Novartis verantwortete sie zudem Phase-3-Startaktivitäten für remibrutinib in Hidradenitis suppurativa.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shattuck Labs Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610010700PRIMZONEFULLFEED9837550) on October 01, 2026, and is solely responsible for the information contained therein.